Health
Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy – News-Medical.Net
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen,…
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen™, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate…
Continue Reading
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoFirst home buyers score early access to deposit scheme